ArticleClinical and molecular hepatology2026

"Surrogates without substance?" Questioning the evidence for histologic improvement with HTD1801: Letter to the editor on "HTD1801 demonstrates promising potential for histologic improvements in metabolic dysfunction-associated steatohepatitis in both a preclinical and phase 2 study".

Zhihao LeiPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.